# Cure Ventures Fund I, L.P. — Form D

Cure Ventures Fund I, L.P. of BOSTON, MA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-05-24. The offering totals $400.0M. Industry: Pooled Investment Fund.

## Offering

- Filed: 2021-05-24
- Form: D
- Accession: 0001863564-21-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $400.0M
- Remaining: $400.0M
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-400415

## Issuer

- Name: Cure Ventures Fund I, L.P.
- CIK: 0001863564
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 351 NEWBURY STREET, 2ND FLOOR, BOSTON, MA, 02115
- Phone: 970-759-6000

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Lou J Tartaglia | Executive Officer | FRAMINGHAM, MA |
| N/A Cure Ventures Fund I GP, LLC | Executive Officer | Boston, MA |
| Louis J Tartaglia | Executive Officer | Boston, MA |
| Dave Fallace | Executive Officer | Boston, MA |
| Richard J Lim | Executive Officer | Billerica, MA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-04-04](https://search.stillhousedata.com/formd/0001863564-23-000001) | D/A | $350.5M | $350.5M |
| [2022-05-20](https://search.stillhousedata.com/formd/0001863564-22-000002) | D/A | $400.0M | $207.9M |

## More

- [CIK 1863564 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1863564&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001863564-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.